{{Rsnum
|rsid=3771362
|Gene=PLCL1
|Chromosome=2
|position=198098107
|Orientation=plus
|GMAF=0.1905
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PLCL1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 55.4 | 39.3 | 5.4
| HCB | 60.6 | 35.8 | 3.6
| JPT | 70.8 | 27.4 | 1.8
| YRI | 85.7 | 12.9 | 1.4
| ASW | 84.2 | 15.8 | 0.0
| CHB | 60.6 | 35.8 | 3.6
| CHD | 57.8 | 35.8 | 6.4
| GIH | 58.4 | 39.6 | 2.0
| LWK | 77.3 | 21.8 | 0.9
| MEX | 67.2 | 29.3 | 3.4
| MKK | 72.4 | 25.0 | 2.6
| TSI | 49.0 | 39.2 | 11.8
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs3771362
|Name_s=
|Gene_s=PLCL1
|Feature=
|Evidence=PubMed ID:18776929
|Annotation=This variant is associated with hip fracture in a GWAS study consisting of 403 chinese females (266 with hip fracture and 177 control subjects).
|Drugs=
|Drug Classes=
|Diseases=Fractures, Bone; Hip Fractures; Hip Injuries; Osteoporosis
|Curation Level=Curated
|PharmGKB Accession ID=PA162316704
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3771362
|overall_frequency_n=26
|overall_frequency_d=128
|overall_frequency=0.203125
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=22
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}